Cargando…

Promoters and inhibitors of treatment adherence among HIV/AIDS patients receiving antiretroviral therapy in Ghana: Narratives from an underserved population

Adherence to antiretroviral therapy (ART) is essential to achieving an improved cluster of differentiation-4 (CD4) count, viral load, and quality of life while preventing drug resistance. Medication adherence among people living with Human Immunodeficiency Virus (HIV) is influenced by different fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Dzansi, Gladys, Tornu, Eric, Chipps, Jeniffer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059913/
https://www.ncbi.nlm.nih.gov/pubmed/32142549
http://dx.doi.org/10.1371/journal.pone.0230159
_version_ 1783504138362945536
author Dzansi, Gladys
Tornu, Eric
Chipps, Jeniffer
author_facet Dzansi, Gladys
Tornu, Eric
Chipps, Jeniffer
author_sort Dzansi, Gladys
collection PubMed
description Adherence to antiretroviral therapy (ART) is essential to achieving an improved cluster of differentiation-4 (CD4) count, viral load, and quality of life while preventing drug resistance. Medication adherence among people living with Human Immunodeficiency Virus (HIV) is influenced by different factors. Several studies have identified adherence promoters and inhibitors that emanate from the internal and external environment. We conducted six (6) individual in-depth interviews and three (3) focus group discussions to explore adherence behaviour among patients diagnosed with HIV in a teaching hospital in Accra, Ghana. Participants were drawn from the intervention arm of a mobile phone adherence intervention program. They had been enrolled in the study for at least six (6) months before the interviews are conducted. Results revealed that participants adhered to treatment irrespective of prompts from significant others. Adherence promoters included perception of ART as part of daily routines, benefits of the ART, awareness of regimen, access to food, and transparency. Adherence inhibitors were forgetfulness, secrecy, waiting time, religious beliefs, and sleep. People living with HIV (PLWHIV) have the personal motivation to take medication; however, negative perceptions about HIV must be addressed to ensure optimum adherence behaviour.
format Online
Article
Text
id pubmed-7059913
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-70599132020-03-12 Promoters and inhibitors of treatment adherence among HIV/AIDS patients receiving antiretroviral therapy in Ghana: Narratives from an underserved population Dzansi, Gladys Tornu, Eric Chipps, Jeniffer PLoS One Research Article Adherence to antiretroviral therapy (ART) is essential to achieving an improved cluster of differentiation-4 (CD4) count, viral load, and quality of life while preventing drug resistance. Medication adherence among people living with Human Immunodeficiency Virus (HIV) is influenced by different factors. Several studies have identified adherence promoters and inhibitors that emanate from the internal and external environment. We conducted six (6) individual in-depth interviews and three (3) focus group discussions to explore adherence behaviour among patients diagnosed with HIV in a teaching hospital in Accra, Ghana. Participants were drawn from the intervention arm of a mobile phone adherence intervention program. They had been enrolled in the study for at least six (6) months before the interviews are conducted. Results revealed that participants adhered to treatment irrespective of prompts from significant others. Adherence promoters included perception of ART as part of daily routines, benefits of the ART, awareness of regimen, access to food, and transparency. Adherence inhibitors were forgetfulness, secrecy, waiting time, religious beliefs, and sleep. People living with HIV (PLWHIV) have the personal motivation to take medication; however, negative perceptions about HIV must be addressed to ensure optimum adherence behaviour. Public Library of Science 2020-03-06 /pmc/articles/PMC7059913/ /pubmed/32142549 http://dx.doi.org/10.1371/journal.pone.0230159 Text en © 2020 Dzansi et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Dzansi, Gladys
Tornu, Eric
Chipps, Jeniffer
Promoters and inhibitors of treatment adherence among HIV/AIDS patients receiving antiretroviral therapy in Ghana: Narratives from an underserved population
title Promoters and inhibitors of treatment adherence among HIV/AIDS patients receiving antiretroviral therapy in Ghana: Narratives from an underserved population
title_full Promoters and inhibitors of treatment adherence among HIV/AIDS patients receiving antiretroviral therapy in Ghana: Narratives from an underserved population
title_fullStr Promoters and inhibitors of treatment adherence among HIV/AIDS patients receiving antiretroviral therapy in Ghana: Narratives from an underserved population
title_full_unstemmed Promoters and inhibitors of treatment adherence among HIV/AIDS patients receiving antiretroviral therapy in Ghana: Narratives from an underserved population
title_short Promoters and inhibitors of treatment adherence among HIV/AIDS patients receiving antiretroviral therapy in Ghana: Narratives from an underserved population
title_sort promoters and inhibitors of treatment adherence among hiv/aids patients receiving antiretroviral therapy in ghana: narratives from an underserved population
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059913/
https://www.ncbi.nlm.nih.gov/pubmed/32142549
http://dx.doi.org/10.1371/journal.pone.0230159
work_keys_str_mv AT dzansigladys promotersandinhibitorsoftreatmentadherenceamonghivaidspatientsreceivingantiretroviraltherapyinghananarrativesfromanunderservedpopulation
AT tornueric promotersandinhibitorsoftreatmentadherenceamonghivaidspatientsreceivingantiretroviraltherapyinghananarrativesfromanunderservedpopulation
AT chippsjeniffer promotersandinhibitorsoftreatmentadherenceamonghivaidspatientsreceivingantiretroviraltherapyinghananarrativesfromanunderservedpopulation